212 related articles for article (PubMed ID: 29088062)
1. A Versatile Chemo-Enzymatic Conjugation Approach Yields Homogeneous and Highly Potent Antibody-Drug Conjugates.
Xu Y; Jin S; Zhao W; Liu W; Ding D; Zhou J; Chen S
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29088062
[TBL] [Abstract][Full Text] [Related]
2. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.
Beerli RR; Hell T; Merkel AS; Grawunder U
PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162
[TBL] [Abstract][Full Text] [Related]
3. Sortase A-Generated Highly Potent Anti-CD20-MMAE Conjugates for Efficient Elimination of B-Lineage Lymphomas.
Pan L; Zhao W; Lai J; Ding D; Zhang Q; Yang X; Huang M; Jin S; Xu Y; Zeng S; Chou JJ; Chen S
Small; 2017 Feb; 13(6):. PubMed ID: 27873460
[TBL] [Abstract][Full Text] [Related]
4. Legomedicine-A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody-Nanoparticle Conjugates.
van Lith SA; van Duijnhoven SM; Navis AC; Leenders WP; Dolk E; Wennink JW; van Nostrum CF; van Hest JC
Bioconjug Chem; 2017 Feb; 28(2):539-548. PubMed ID: 28045502
[TBL] [Abstract][Full Text] [Related]
5. Engineering Antibodies with C-Terminal Sortase-Mediated Modification for Targeted Nanomedicine.
Hashad RA; Lange JL; Tan NCW; Alt K; Hagemeyer CE
Methods Mol Biol; 2019; 2033():67-80. PubMed ID: 31332748
[TBL] [Abstract][Full Text] [Related]
6. Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry.
VanBrunt MP; Shanebeck K; Caldwell Z; Johnson J; Thompson P; Martin T; Dong H; Li G; Xu H; D'Hooge F; Masterson L; Bariola P; Tiberghien A; Ezeadi E; Williams DG; Hartley JA; Howard PW; Grabstein KH; Bowen MA; Marelli M
Bioconjug Chem; 2015 Nov; 26(11):2249-60. PubMed ID: 26332743
[TBL] [Abstract][Full Text] [Related]
7. Elimination of melanoma by sortase A-generated TCR-like antibody-drug conjugates (TL-ADCs) targeting intracellular melanoma antigen MART-1.
Lai J; Wang Y; Wu SS; Ding D; Sun ZY; Zhang Y; Zhou J; Zhou Z; Xu YC; Pan LQ; Chen SQ
Biomaterials; 2018 Sep; 178():158-169. PubMed ID: 29933102
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of precision antibody conjugates using proximity-induced chemistry.
Cao YJ; Yu C; Wu KL; Wang X; Liu D; Tian Z; Zhao L; Qi X; Loredo A; Chung A; Xiao H
Theranostics; 2021; 11(18):9107-9117. PubMed ID: 34522229
[No Abstract] [Full Text] [Related]
9. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion.
Dimasi N; Fleming R; Zhong H; Bezabeh B; Kinneer K; Christie RJ; Fazenbaker C; Wu H; Gao C
Mol Pharm; 2017 May; 14(5):1501-1516. PubMed ID: 28245132
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminase-based chemo-enzymatic conjugation approach yields homogeneous antibody-drug conjugates.
Dennler P; Chiotellis A; Fischer E; Brégeon D; Belmant C; Gauthier L; Lhospice F; Romagne F; Schibli R
Bioconjug Chem; 2014 Mar; 25(3):569-78. PubMed ID: 24483299
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic conjugation using branched linkers for constructing homogeneous antibody-drug conjugates with high potency.
Anami Y; Xiong W; Gui X; Deng M; Zhang CC; Zhang N; An Z; Tsuchikama K
Org Biomol Chem; 2017 Jul; 15(26):5635-5642. PubMed ID: 28649690
[TBL] [Abstract][Full Text] [Related]
12. Preparation of bispecific antibody-protein adducts by site-specific chemo-enzymatic conjugation.
Bartels L; Ploegh HL; Spits H; Wagner K
Methods; 2019 Feb; 154():93-101. PubMed ID: 30081077
[TBL] [Abstract][Full Text] [Related]
13. Site-Specific Modification of Single-Chain Antibody Fragments for Bioconjugation and Vascular Immunotargeting.
Greineder CF; Villa CH; Walsh LR; Kiseleva RY; Hood ED; Khoshnejad M; Warden-Rothman R; Tsourkas A; Muzykantov VR
Bioconjug Chem; 2018 Jan; 29(1):56-66. PubMed ID: 29200285
[TBL] [Abstract][Full Text] [Related]
14. Fast and Efficient Fc-Specific Photoaffinity Labeling To Produce Antibody-DNA Conjugates.
Stiller C; Aghelpasand H; Frick T; Westerlund K; Ahmadian A; Karlström AE
Bioconjug Chem; 2019 Nov; 30(11):2790-2798. PubMed ID: 31609586
[TBL] [Abstract][Full Text] [Related]
15. Sortase-click strategy for defined protein conjugation on a heptavalent cyclodextrin scaffold.
Singh S; Gupta K; Shukla S; Sampathkumar SG; Roy RP
PLoS One; 2019; 14(5):e0217369. PubMed ID: 31125361
[TBL] [Abstract][Full Text] [Related]
16. Development of potent monoclonal antibody auristatin conjugates for cancer therapy.
Doronina SO; Toki BE; Torgov MY; Mendelsohn BA; Cerveny CG; Chace DF; DeBlanc RL; Gearing RP; Bovee TD; Siegall CB; Francisco JA; Wahl AF; Meyer DL; Senter PD
Nat Biotechnol; 2003 Jul; 21(7):778-84. PubMed ID: 12778055
[TBL] [Abstract][Full Text] [Related]
17. Antibody drug conjugates.
Bakhtiar R
Biotechnol Lett; 2016 Oct; 38(10):1655-64. PubMed ID: 27334710
[TBL] [Abstract][Full Text] [Related]
18. A new construct of antibody-drug conjugates for treatment of B-cell non-Hodgkin's lymphomas.
Zhang L; Fang Y; Kopeček J; Yang J
Eur J Pharm Sci; 2017 May; 103():36-46. PubMed ID: 28249824
[TBL] [Abstract][Full Text] [Related]
19. Molecularly defined antibody conjugation through a selenocysteine interface.
Hofer T; Skeffington LR; Chapman CM; Rader C
Biochemistry; 2009 Dec; 48(50):12047-57. PubMed ID: 19894757
[TBL] [Abstract][Full Text] [Related]
20. Antibody-Drug Conjugates for Tumor Targeting-Novel Conjugation Chemistries and the Promise of non-IgG Binding Proteins.
Merten H; Brandl F; Plückthun A; Zangemeister-Wittke U
Bioconjug Chem; 2015 Nov; 26(11):2176-85. PubMed ID: 26086208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
